At a glance
ClinicalIndex Comparison RecordN/ACompleted· 25 enrolled
Drug / intervention
GO-EXCAP Mobile Appbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Mobile Health Exercise Intervention for Older Patients With Myeloid Neoplasms
In Brief
A clinical study evaluating GO-EXCAP Mobile App for Intervention. Completed, enrolled 25 participants across 1 site.
Detailed Summary
This is a pilot study to evaluate the feasibility of a mobile health exercise intervention (GO-EXCAP Mobile App) over 7 weeks in 25 patients with myeloid neoplasms receiving hypomethylating agents.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIntervention
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedJul 2019
Enrollment StartFeb 2020
Primary CompletionOct 2021
TodayJul 2026
First PostedJul 29, 2019
Enrollment StartFeb 1, 2020
Primary CompletionOct 31, 2021
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 6.9 years ago
Interventions
GO-EXCAP Mobile Appbehavioral
A mobile app delivery platform and the EXCAP©® exercise program